广生堂(300436)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300436 广生堂

午间休市 07-24 11:30:00

{"stockData":{"symbol":"300436","market":"SZ","secType":"STK","nameCN":"广生堂","latestPrice":87.57,"timestamp":1784863800000,"preClose":88.88,"halted":0,"volume":2287187,"delay":0,"changeRate":-0.0147,"floatShares":137000000,"shares":159000000,"eps":-1.3518,"marketStatus":"午间休市","change":-1.31,"latestTime":"07-24 11:30:00","open":87.8,"high":89.3,"low":86.99,"amount":201000000,"amplitude":0.026,"askPrice":87.57,"askSize":15,"bidPrice":87.45,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-1.3518,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784869200000},"marketStatusCode":3,"adr":0,"adjPreClose":88.88,"symbolType":"stock","openAndCloseTimeList":[[1784856600000,1784863800000],[1784869200000,1784876400000]],"highLimit":97.77,"lowLimit":79.99,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":159267000,"isCdr":false,"pbRate":56.26,"roa":"--","roe":"--","epsLYR":-1.3678,"committee":-0.263158,"marketValue":13947000000,"turnoverRate":0.0167,"status":1,"floatMarketCap":11973000000},"requestUrl":"/m/hq/s/300436/tweets","defaultTab":"tweets","newsList":[{"id":"2652406128","title":"7月17日广生堂跌13.16%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406128","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652406128?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:52","pubTimestamp":1784278353,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日广生堂跌13.16%，收盘报89.6元，换手率7.68%，成交量10.5万手，成交额10.14亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.3742，较上一交易日下跌3.66%，近一年上涨28.2%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651745533","title":"7月15日广生堂涨6.09%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651745533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651745533?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:34","pubTimestamp":1784104483,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日广生堂涨6.09%，收盘报103.97元，换手率10.12%，成交量13.84万手，成交额14.36亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.5303，较上一交易日上涨5.97%，近一年上涨35.04%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651455854","title":"广生堂涨6.09%，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2651455854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651455854?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:34","pubTimestamp":1784104477,"startTime":"0","endTime":"0","summary":"今日广生堂涨6.09%，收盘报103.97元。2026年5月20日，中邮证券研究员盛丽华,辛家齐发布了对广生堂的研报《创新药突破，核心业务彰显韧性》，该研报对广生堂给出“买入”评级。公司是肝病治疗药物领军企业，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中邮证券的盛丽华、陈成。广生堂个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648828503","title":"7月2日广生堂跌6.01%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648828503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648828503?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:45","pubTimestamp":1782981942,"startTime":"0","endTime":"0","summary":"证券之星消息，7月2日广生堂跌6.01%，收盘报105.8元，换手率10.65%，成交量14.57万手，成交额15.94亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.7851，较上一交易日下跌3.76%，近一年上涨48.45%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647653506","title":"近260家公司获机构调研，广生堂最受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2647653506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647653506?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:31","pubTimestamp":1782808260,"startTime":"0","endTime":"0","summary":"从接待机构数量来看，广生堂以一周接待53家机构的成绩位居榜首，成为上周最受关注的公司。胜宏科技以45家机构的接待量并列上周第三。公司表示，目前已有部分ASIC相关PCB产品进行批量生产，业务进展顺利。盛弘股份吸引了44家机构参与电话调研，位列上周第四。奥比中光接待了36家机构参与现场参观、券商策略会、路演活动及电话会议，位列上周第五。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2026063000029527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322163","title":"6月29日广生堂涨20.00%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322163?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:51","pubTimestamp":1782723076,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日广生堂涨20.00%，收盘报106.56元，换手率9.92%，成交量13.56万手，成交额13.63亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.8132，较上一交易日下跌4.35%，近一年上涨53.89%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647132212","title":"广生堂涨20.00%，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647132212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647132212?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:51","pubTimestamp":1782723063,"startTime":"0","endTime":"0","summary":"今日广生堂涨20.00%，收盘报106.56元。2026年5月20日，中邮证券研究员盛丽华,辛家齐发布了对广生堂的研报《创新药突破，核心业务彰显韧性》，该研报对广生堂给出“买入”评级。公司是肝病治疗药物领军企业，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中邮证券的盛丽华、陈成。广生堂个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647432974","title":"6月29日广生堂（300436）涨停分析：乙肝新药获批临床、新冠药进展加速驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2647432974","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647432974?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:36","pubTimestamp":1782718571,"startTime":"0","endTime":"0","summary":"证券之星消息，广生堂6月29日涨停收盘，收盘价106.56元。6月29日广生堂涨停的可能因素有：公司核心产品GST-HG141于6月下旬获CDE批准进入II期临床试验，属国内首个进入临床的同类创新药；同时，其口服抗新冠小分子药物GST-HG171已完成I期临床并启动国际多中心II/III期筹备，近期获多家券商深度报告重点推荐；此外，公司入选创业板医药生物成分股调整名单，市场关注度显著提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647473833","title":"557个药品进医保初审！创新药集体走强，广生堂20CM涨停_手机新浪网","url":"https://stock-news.laohu8.com/highlight/detail?id=2647473833","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647473833?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:34","pubTimestamp":1782700447,"startTime":"0","endTime":"0","summary":"557个药品进医保初审！创新药集体走强，广生堂20CM涨停    分时图\r\n\r\n　　6月29日消息，创新药概念持续拉升，广生堂20cm涨停，新华制药、济民健康、太龙药业等多股涨停。\r\n\r\n　　消息面上，国家医保局6月29日对通过2026年目录初审的药品名单和主要信息进行公示，其中557个、54个药品分别通过基本医保药品目录、商保创新药目录初步形式审查。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/29/20260629618945.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/29/20260629618945.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260629/32292731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300436","BK0239","BK1574","BK1161","159992","SINA","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645881113","title":"6月23日广生堂涨6.01%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645881113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645881113?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:39","pubTimestamp":1782203950,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日广生堂涨6.01%，收盘报93.07元，换手率7.99%，成交量10.92万手，成交额10.11亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.8768，较上一交易日上涨1.68%，近一年上涨63.26%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645629881","title":"广生堂涨6.01%，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645629881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645629881?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:38","pubTimestamp":1782203936,"startTime":"0","endTime":"0","summary":"今日广生堂涨6.01%，收盘报93.07元。2026年5月20日，中邮证券研究员盛丽华,辛家齐发布了对广生堂的研报《创新药突破，核心业务彰显韧性》，该研报对广生堂给出“买入”评级。公司是肝病治疗药物领军企业，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中邮证券的盛丽华、陈成。广生堂个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645961580","title":"每周股票复盘：广生堂（300436）定增获深交所审核通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2645961580","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645961580?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:09","pubTimestamp":1781982551,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，广生堂报收于88.15元，较上周的87.01元上涨1.31%。公司公告汇总关于向特定对象发行股票申请获得深圳证券交易所上市审核中心审核通过的公告福建广生堂药业股份有限公司于2026年6月15日收到深圳证券交易所上市审核中心出具的《关于福建广生堂药业股份有限公司申请向特定对象发行股票的审核中心意见告知函》。本次发行已通过深交所审核，尚需中国证监会注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116586","title":"6月5日广生堂跌7.04%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116586?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:43","pubTimestamp":1780649036,"startTime":"0","endTime":"0","summary":"证券之星消息，6月5日广生堂跌7.04%创60日新低，收盘报88.81元，换手率7.78%，成交量10.64万手，成交额9.71亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.5926，较上一交易日上涨0.77%，近一年上涨45.09%。广发双擎升级混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943225","title":"广生堂：揭盲工作将在所有患者完成48周治疗后进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640943225?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:53","pubTimestamp":1780404803,"startTime":"0","endTime":"0","summary":"证券之星消息，广生堂06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司141三期临床首例首批患者入组已经44周了，48周是否会对首批患者的实验结果进行揭盲公示呢？根据当前临床试验设计，未设置中期揭盲，揭盲工作将在所有患者完成48周治疗后进行，以确保试验结果的科学性与数据完整性。如有重要进展，公司将通过公告等方式及时向投资者披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200044839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943199","title":"广生堂：GST-HG141的III期临床试验已完成全部受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640943199?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:51","pubTimestamp":1780404681,"startTime":"0","endTime":"0","summary":"证券之星消息，广生堂06月01日在投资者关系平台上答复投资者关心的问题。其中，GST-HG141的III期临床试验已完成全部受试者入组，正严格按既定方案和计划稳步推进。公司将全力以赴推进创新药临床研发，以长期成果回报股东的信任与支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200044710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632714346","title":"每周股票复盘：广生堂（300436）2025年净亏超2亿不分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2632714346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632714346?lang=zh_cn&edition=full","pubTime":"2026-05-03 02:10","pubTimestamp":1777745419,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，广生堂报收于117.3元，较上周的113.3元上涨3.53%。本周，广生堂4月29日盘中最高价报121.99元。来自公司公告汇总：因2025年度亏损，公司决定不派发现金红利、不送红股、不以资本公积金转增股本。股本股东变化股东户数变动截至2026年3月31日，广生堂股东户数为3.49万户，较2025年12月31日增加551.0户，增幅1.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631652007","title":"广生堂（300436）2026年一季报简析：营收上升亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2631652007","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631652007?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:42","pubTimestamp":1777502555,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广生堂发布2026年一季报。根据财报显示，广生堂营收上升亏损收窄。其中，毛利率66.95%，同比增2.02%，净利率-30.6%，同比减1.16%，销售费用、管理费用、财务费用总计7822.72万元，三费占营收比79.47%，同比减5.86%，每股净资产1.58元，同比减24.15%，每股经营性现金流-0.13元，同比减60.02%，每股收益-0.16元，同比增9.0%证券之星价投圈财报分析工具显示：业务评价：去年的净利率为-58.08%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631787515","title":"广生堂（300436）披露2025年度利润分配预案：拟不派现、不送股、不转增，4月29日股价上涨9.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631787515","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631787515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:48","pubTimestamp":1777463291,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，广生堂报收于116.81元，较前一交易日上涨9.31%，最新总市值为186.04亿元。该股当日开盘110.67元，最高121.99元，最低110.67元，成交额达15.59亿元，换手率为9.75%。广生堂于近日披露《关于2025年度利润分配方案的专项说明公告》。公告显示，公司于2026年4月27日召开第五届董事会第十六次会议，审议通过《关于2025年度利润分配预案的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631917560","title":"4月29日广生堂涨9.31%，广发双擎升级混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631917560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631917560?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:38","pubTimestamp":1777451895,"startTime":"0","endTime":"0","summary":"证券之星消息，4月29日广生堂涨9.31%，收盘报116.81元，换手率9.75%，成交量13.33万手，成交额15.59亿元。重仓广生堂的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的广发双擎升级混合A。广发双擎升级混合A目前规模为46.53亿元，最新净值2.5422，较上一交易日上涨0.12%，近一年上涨40.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900052322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300436"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631683582","title":"图解广生堂年报：第四季度单季净利润同比下降24.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631683582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631683582?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:16","pubTimestamp":1777396602,"startTime":"0","endTime":"0","summary":"证券之星消息，广生堂2025年年报显示，当年度公司主营收入4.16亿元，同比下降5.68%；归母净利润-2.18亿元，同比下降39.37%；扣非净利润-2.26亿元，同比下降13.02%；其中2025年第四季度，公司单季度主营收入1.01亿元，同比下降12.69%；单季度归母净利润-1.06亿元，同比下降24.05%；单季度扣非净利润-1.08亿元，同比上升7.07%；负债率75.27%，投资收益-315.03万元，财务费用3267.56万元，毛利率62.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900003616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300436"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784863829104,"stockEarnings":[{"period":"1week","weight":-0.1386},{"period":"1month","weight":-0.045},{"period":"3month","weight":-0.2155},{"period":"6month","weight":-0.0769},{"period":"1year","weight":0.2226},{"period":"ytd","weight":-0.003}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.0498},{"period":"6month","weight":-0.0627},{"period":"1year","weight":0.0822},{"period":"ytd","weight":-0.0232}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福建广生堂药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34937人(较上一季度增加1.60%)","perCapita":"3913股","listingDate":"2015-04-22","address":"福建省宁德市柘荣县富源工业园区1-7幢","registeredCapital":"15926万元","survey":"　　福建广生堂药业股份有限公司的主营业务是核苷类抗乙肝病毒药物的研发、生产与销售。公司的主要产品是肝胆疾病药物、呼吸系统药物、心血管药物、男性健康产品。","listedPrice":21.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广生堂(300436)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广生堂(300436)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广生堂,300436,广生堂股票,广生堂股票老虎,广生堂股票老虎国际,广生堂行情,广生堂股票行情,广生堂股价,广生堂股市,广生堂股票价格,广生堂股票交易,广生堂股票购买,广生堂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广生堂(300436)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广生堂(300436)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}